Hiroshi Abe

1.5k total citations
63 papers, 725 citations indexed

About

Hiroshi Abe is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Hiroshi Abe has authored 63 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 38 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Hiroshi Abe's work include Hepatitis C virus research (32 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (19 papers). Hiroshi Abe is often cited by papers focused on Hepatitis C virus research (32 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (19 papers). Hiroshi Abe collaborates with scholars based in Japan, India and South Korea. Hiroshi Abe's co-authors include Yoshio Aizawa, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Keizo Kato, Katsuhiko Iwakiri, Chisa Kondo, Norio Itokawa, Tomomi Okubo and Taeang Arai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Gut.

In The Last Decade

Hiroshi Abe

56 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Abe Japan 16 472 457 83 66 62 63 725
Renuka Bhattacharya United States 13 391 0.8× 377 0.8× 19 0.2× 25 0.4× 63 1.0× 33 710
Shu-Hui Zhan China 9 659 1.4× 754 1.6× 18 0.2× 29 0.4× 31 0.5× 19 972
J.-P. Bronowicki France 14 641 1.4× 498 1.1× 61 0.7× 54 0.8× 66 1.1× 27 796
Lein‐Ray Mo Taiwan 18 343 0.7× 388 0.8× 87 1.0× 12 0.2× 57 0.9× 76 1.2k
Massimo Siciliano Italy 16 595 1.3× 449 1.0× 33 0.4× 16 0.2× 34 0.5× 55 752
Michael Dürr Germany 21 53 0.1× 320 0.7× 41 0.5× 124 1.9× 44 0.7× 50 1.2k
Beijian Huang China 23 306 0.6× 230 0.5× 42 0.5× 23 0.3× 80 1.3× 72 1.3k
Yongfeng Yang China 15 119 0.3× 210 0.5× 11 0.1× 54 0.8× 25 0.4× 65 643
Masahiro Kyo Japan 12 178 0.4× 165 0.4× 20 0.2× 41 0.6× 34 0.5× 74 683
Xiaojun Tan China 9 88 0.2× 118 0.3× 15 0.2× 28 0.4× 15 0.2× 25 403

Countries citing papers authored by Hiroshi Abe

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Abe more than expected).

Fields of papers citing papers by Hiroshi Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Abe. The network helps show where Hiroshi Abe may publish in the future.

Co-authorship network of co-authors of Hiroshi Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Abe. A scholar is included among the top collaborators of Hiroshi Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Abe. Hiroshi Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arai, Taeang, Masanori Atsukawa, Akihito Tsubota, et al.. (2024). Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study. Diabetes Obesity and Metabolism. 26(11). 4958–4965. 15 indexed citations
2.
3.
Toyoda, Hidenori, Satoshi Yasuda, Akio Moriya, et al.. (2022). Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy. Journal of Infection and Chemotherapy. 28(9). 1231–1234. 1 indexed citations
4.
Kato, Keizo, Noritomo Shimada, Masanori Atsukawa, et al.. (2019). Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C. PLoS ONE. 14(7). e0219022–e0219022. 2 indexed citations
5.
Okubo, Tomomi, Masanori Atsukawa, Akihito Tsubota, et al.. (2018). Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment. Hepatology International. 12(2). 133–142. 16 indexed citations
6.
Kato, Keizo, Hiroshi Abe, Ryota Matsuo, et al.. (2018). Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder. Clinical Journal of Gastroenterology. 11(5). 401–410. 11 indexed citations
7.
Atsukawa, Masanori, Akihito Tsubota, Chisa Kondo, et al.. (2017). Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C. Digestive and Liver Disease. 49(9). 1029–1035. 11 indexed citations
8.
Iio, Etsuko, Noritomo Shimada, Hiroshi Abe, et al.. (2016). Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1. Journal of Gastroenterology. 52(1). 94–103. 32 indexed citations
9.
Abe, Hiroshi, et al.. (2016). Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles. World Journal of Gastroenterology. 22(29). 6716–6716. 3 indexed citations
10.
Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2014). Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C. Digestive and Liver Disease. 46(8). 738–743. 14 indexed citations
11.
Yoshikawa, Kenichi, et al.. (2014). Early syphilitic hepatitis concomitant with nephrotic syndrome followed by acute kidney injury. Clinical Journal of Gastroenterology. 7(4). 349–354. 7 indexed citations
12.
Abe, Hiroshi, et al.. (2014). Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2. Hepatology International. 8(4). 550–559. 9 indexed citations
13.
14.
Tanaka, Ken‐ichiro, Tomokazu Matsuura, Daisuke Shindo, et al.. (2013). Noninvasive assessment of insulin resistance in the liver using the fasting 13C-glucose breath test. Translational research. 162(3). 191–200. 7 indexed citations
15.
16.
Hayes, C. Nelson, Norio Akuta, Fumitaka Suzuki, et al.. (2010). HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy. Gut. 60(2). 261–267. 83 indexed citations
17.
Abe, Hiroshi, et al.. (2008). Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. Journal of Gastroenterology. 43(12). 967–974. 48 indexed citations
18.
Tomimatsu, Masahiko, Yoshio Aizawa, Yoshimichi Chuganji, et al.. (2006). Treatment effects and predictors of a 24‐week course of interferon α‐2b plus ribavirin combination therapy for patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 21(7). 1177–1183.
19.
Ikeda, Jun, Yutaka Sawamura, Tsutomu Katô, & Hiroshi Abe. (1998). Metachronous neurohypophyseal germinoma occurring 8 years after total resection of pineal mature teratoma. Surgical Neurology. 49(2). 205–208. 22 indexed citations
20.
Saito, Yoshinori, Hiroshi Abe, Hiroo Niiyama, & Etsuro Echigoya. (1986). Measurements of acidic property of 12-tungstophosphates.. NIPPON KAGAKU KAISHI. 25–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renuka Bhattacharya Breakdown of academic impact, for papers by Shu-Hui Zhan Breakdown of academic impact, for papers by J.-P. Bronowicki Breakdown of academic impact, for papers by Lein‐Ray Mo Breakdown of academic impact, for papers by Massimo Siciliano Breakdown of academic impact, for papers by Michael Dürr Breakdown of academic impact, for papers by Beijian Huang Breakdown of academic impact, for papers by Yongfeng Yang Breakdown of academic impact, for papers by Masahiro Kyo Breakdown of academic impact, for papers by Xiaojun Tan
Rankless by CCL
2026